Highly Fluctuating Thrombocytopenia Developing in a Patient with Immune Thrombocytopenia (ITP) while Administering Romiplostim-Reference-Cited by-同舟云学术

Highly Fluctuating Thrombocytopenia Developing in a Patient with Immune Thrombocytopenia (ITP) while Administering Romiplostim

Published:2012 Issue:11 Volume:51 Page:1399-1401
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Shinohara Kenji¹,Kambara Naoko¹

Affiliation:

1. Department of Medicine, Towa Municipal Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/11/51_51.7106/_pdf

Reference12 articles.

1. 1. Bussel JB, Kuter DJ, Phil DP, et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355: 1672-1681, 2006.

2. 2. Kuter D J, Bussel J B, Lyons R M, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial. Lancet 371: 395-403, 2008.

3. 3. Kuter D J. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 60: 193-206, 2009.

4. 4. Kuter D J, Phil D, Rummel M, et al. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med 363: 1889-1899, 2010.

5. 5. Cuker A. Toxicities of the thrombopoietic growth factors. Semin Hematol 47: 289-298, 2010.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching between eltrombopag and recombinant human thrombopoietin in patients with immune thrombocytopenia: an observational study;Chinese Medical Journal;2022-10-05

2. Thrombopoietin Receptor Agonist in Pregnancy: a Case For Romiplostim in Refractory Immune Thrombocytopenic Purpura;SN Comprehensive Clinical Medicine;2022-06-25

3. EFFICACY AND SAFETY OF THROMBOPOIETIN RECEPTOR AGONISTS IN MODERN TREATMENT OF IMMUNE THROMBOCYTOPENIA;FARMACIA;2021-04-20

4. Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia;Therapeutic Advances in Hematology;2019-01

5. Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports;Journal of Oncology Pharmacy Practice;2018-01-22